U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7299172991Ranibizumab and Bevacizumab for Diabetic Macular EdemaActive, not recruitingNo Results AvailableDiabetic Macular EdemaDrug: Ranibizumab and Bevacizumab|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01610557
729927299218F FLT Imaging Studies of Treatment Response for Lung Cancer and ThymomaWithdrawnNo Results AvailableCarcinoma, Non-Small-Cell Lung|Thymus NeoplasmsDrug: 3'-deoxy-3'-18F fluorothymidine (FLT)|Other: PET/CT scanhttps://ClinicalTrials.gov/show/NCT01610544
7299372993COPARIME: Pilot Study of a Target Detection of Malignant MelanomaRecruitingNo Results AvailablePatients at Risk for MelanomaOther: SAMScore questionnairehttps://ClinicalTrials.gov/show/NCT01610531
7299472994The Glycemic Response Elicited by Beta-glucans of Different Physical Properties and FormCompletedNo Results AvailableType 2 DiabetesDietary Supplement: oat beta-glucan|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01610518
7299572995A Study of the KineSpring System Versus High Tibial Osteotomy Surgery for the Treatment of Medial Compartment Knee OsteoarthritisEnrolling by invitationNo Results AvailableOsteoarthritisDevice: Medial knee compartment osteoarthritis treatment - surgicalhttps://ClinicalTrials.gov/show/NCT01610505
7299672996A Study of Belimumab in Idiopathic Membranous GlomerulonephropathyActive, not recruitingHas ResultsGlomerulonephritis, MembranousDrug: belimumabhttps://ClinicalTrials.gov/show/NCT01610492
7299772997A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid TumorsRecruitingNo Results AvailableAdvanced Solid TumorsDrug: TAS-114 + S-1https://ClinicalTrials.gov/show/NCT01610479
7299872998Design and Validation of a Simulation-based Training Curriculum for Laparoscopic Bariatric SurgeryRecruitingNo Results AvailableObesityProcedure: Laparoscopic bariatric surgery ex-vivo training curriculumhttps://ClinicalTrials.gov/show/NCT01610466
7299972999Prediction of Delivery With Transperineal Ultrasound in Women With Prolonged Labour. Multicentre StudyCompletedNo Results AvailableFailed LaborProcedure: ultrasound examinationhttps://ClinicalTrials.gov/show/NCT01610453
7300073000Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular DystrophyRecruitingNo Results AvailableDuchenne Muscular DystrophyBiological: human umbilical cord mesenchymal stem cellshttps://ClinicalTrials.gov/show/NCT01610440
7300173001Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected SubjectsCompletedNo Results AvailableAIDSProcedure: Blood sample collectionhttps://ClinicalTrials.gov/show/NCT01610427
7300273002Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173AActive, not recruitingNo Results AvailableHerpes ZosterBiological: Herpes Zoster vaccine GSK1437173A|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01610414
7300373003The Metformin-FMD TrialCompletedNo Results AvailableIschemia Reperfusion Injury|Endothelial FunctionDrug: Metformin|Drug: Pretreatment with metformin in combination of infusion of caffeine.|Drug: No pretreatment with metformin in combination with infusion of caffeinehttps://ClinicalTrials.gov/show/NCT01610401
7300473004A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy SubjectsCompletedNo Results AvailableInfections, BacterialDrug: 500mg IV GSK1322322/placebo|Drug: 1000mg oral GSK1322322/placebo|Drug: 1000mg IV GSK1322322/placebo|Drug: 1500mg oral GSK1322322/placebo dose|Drug: 1500mg IV GSK1322322/placebo|Drug: 2000mg IV GSK1322322J/placebo|Drug: 3000mg IV GSK1322322J/placebo|Drug: 1000mg IV GSK1322322J/placebohttps://ClinicalTrials.gov/show/NCT01610388
7300573005Telephone Follow-up After Treatment for Endometrial CancerActive, not recruitingNo Results AvailableEndometrial CancerOther: Telephone Follow-uphttps://ClinicalTrials.gov/show/NCT01610375
7300673006Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune ResponseRecruitingNo Results AvailableRabiesBiological: Human Rabies Immune Globulinhttps://ClinicalTrials.gov/show/NCT01610362
7300773007[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01610349
7300873008A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi TreatmentRecruitingNo Results AvailableNon-small Cell Lung CancerDrug: INC280https://ClinicalTrials.gov/show/NCT01610336
7300973009Fitness Improvement in Obese, Pregnant Women: an Intervention TrialCompletedNo Results AvailablePregnancy|Obesity|Physical ActivityOther: Exercise intervention|Other: Standard Carehttps://ClinicalTrials.gov/show/NCT01610323
7301073010Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy VolunteersCompletedNo Results AvailableHealthy|Multiple SclerosisDevice: BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS)|Device: BIIB017 (peginterferon beta-1a) Autoinjectorhttps://ClinicalTrials.gov/show/NCT01610310
7301173011Post Hematopoietic Stem Cell TransplantationActive, not recruitingNo Results AvailableIron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia MajorDrug: ICL670https://ClinicalTrials.gov/show/NCT01610297
7301273012Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorActive, not recruitingNo Results AvailableBreast CancerDrug: BKM120 Matching placebo|Drug: Fulvestrant|Drug: BKM120https://ClinicalTrials.gov/show/NCT01610284
7301373013Air Barrier System for the Prevention of Surgical Site InfectionCompletedNo Results AvailableSurgical Site InfectionDevice: Air Barrier System (Nimbic)https://ClinicalTrials.gov/show/NCT01610271
7301473014Maternal Plasmatic Regulatory T Cells and Th17 as Possible Diagnosis Markers of Acute ChorioamnionitisRecruitingNo Results AvailablePathology of PregnancyOther: Blood and placenta sampleshttps://ClinicalTrials.gov/show/NCT01610258
7301573015Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNo Results AvailableInfluenzaDrug: Nitazoxanide|Drug: Oseltamivirhttps://ClinicalTrials.gov/show/NCT01610245
7301673016Infrared-LED During Physical Training for Rehabilitation, Physical Performance and Body AestheticsCompletedNo Results AvailableHealthyDevice: Photon stimulation by light-emitting diodes (LEDs)|Other: Treadmill traininghttps://ClinicalTrials.gov/show/NCT01610232
7301773017Lifestyle Modification for Type 2 Diabetes Prevention in Overweight YouthCompletedNo Results AvailableDiabetes Mellitus, Type 2|ObesityBehavioral: Lifestyle Modification for Type 2 Diabetes Prevention|Other: Nutrition and Physical Activityhttps://ClinicalTrials.gov/show/NCT01610219
7301873018A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian CancerRecruitingNo Results AvailableOvarian Cancer|Fallopian Tube Cancer|Peritoneal CancerDrug: Gemcitabine|Drug: pazopanibhttps://ClinicalTrials.gov/show/NCT01610206
7301973019The Value of Pancreatic Stone Protein in Predicting Acute AppendicitisRecruitingNo Results AvailableAppendicitis|Abdominal Pain|Abdominal SepsisProcedure: Appendicectomyhttps://ClinicalTrials.gov/show/NCT01610193
7302073020Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)RecruitingNo Results AvailablePurpura, Thrombocytopenic, Idiopathic|Autoimmune Thrombocytopenic Purpura|Autoimmune Thrombocytopenia|Chronic Lymphocytic Leukemia|Non Hodgkin's LymphomaDrug: Eltrombopag Olaminehttps://ClinicalTrials.gov/show/NCT01610180

* Görseller ve İçerik tekif hakkına sahip olabilir